Xi'an Tourism (000610.SZ) has applied for the issuance of stocks to specific individuals and the application has been accepted by the Shenzhen Stock Exchange.

11:45 25/03/2026

Xi'an Tourism (000610.SZ) announced that the company recently received a notice from the Shenzhen Stock Exchange (referred to as "SZSE") titled "Notice of Acceptance of Xi'an Tourism Co., Ltd.'s Application for Issuance of Shares to Specific Objects" (SZSE Reply [2026] No. 49). The SZSE checked the application documents submitted by the company for the issuance of shares to specific objects, deemed the application documents complete, and decided to accept the application.

Xi'an Tourism (000610.SZ) announced that the company recently received a notice from the Shenzhen Stock Exchange (referred to as "SZSE") regarding the acceptance of Xi'an Tourism Co., Ltd.'s application for issuing shares to specific entities (SZSE acceptance notice No. SZSSE Audit [2026] No. 49). The SZSE has checked the application documents submitted by the company for issuing shares to specific entities, and believes that the application documents are complete, and has decided to accept the application.

BIOSTAR PHARM-B(02563): Expected audit reservation opinion

MNSO (09896) spent $228,500 on March 24 to buy back 55,600 shares.

UNITED LAB(03933): Phase II clinical study of class 1 innovative drug UBT251 injection has been completed in Chinese type 2 diabetes patients.

BIOSTAR PHARM-B(02563): Expected audit reservation opinion

MNSO (09896) spent $228,500 on March 24 to buy back 55,600 shares.

UNITED LAB(03933): Phase II clinical study of class 1 innovative drug UBT251 injection has been completed in Chinese type 2 diabetes patients.